Technology News and Research

RSS

BrainScope sponsors 'B-Ahead U.K. Trial' to assess traumatic brain injury

BrainScope Company, today announced its sponsorship of a multi-center, observational clinical study, the "B-Ahead U.K. Trial", utilizing its technology in development to aid in the assessment of traumatic brain injury and its milder forms in emergency departments in the United Kingdom.

27 Jan 2011

GE's Pathology Imaging Centre of Excellence receives HTX investment under Ontario Flagship Program

HTX announced today an agreement to establish GE's first global Pathology Imaging Centre of Excellence in Toronto, Ontario. GE Healthcare and its digital pathology joint venture, Omnyx™, will invest $7.75M along with a $2.25M grant from the Health Technology Exchange (HTX). Planned collaborative research and development (R&D) partnerships will bring an additional $7.2M, for a total investment of $17.2M over the next 3 years.

27 Jan 2011

State of the Union address includes brief, but clear, defense of health law

President Barack Obama made clear that he is willing to tinker around the edges of the sweeping reform, but not return to the days before the measure became law. Media outlets analyzed the specifics of his comments and offered a big picture view of the impact of the entire speech, including fact-checking some of his related policy ideas and budget recommendations.

27 Jan 2011

Pfenex receives $3.1 million SAIC sub-contract to develop malaria antigen

Pfenex today announced that Science Applications International Corporation has awarded Pfenex a sub-contract valued at $3.1 million to help develop a robust, scalable, cGMP ready production process for large scale production of full length Circumsporozoite protein from Plasmodium falciparum.

27 Jan 2011

QIAGEN announces formation of subsidiary in India

QIAGEN today announced the formation of its India subsidiary, QIAGEN India Pvt. Ltd., and the beginning of direct sales in the country. Until now, QIAGEN products have been sold in India through distributor partnerships.

From QIAGEN Manchester Limited 27 Jan 2011

New Center for Precision Joint Replacement opens at Salt Lake Regional Medical Center

Salt Lake Regional Medical Center today announced the grand opening of the hospital's Center for Precision Joint Replacement, which specializes in the practice of complex knee, hip and shoulder joint replacements in Utah.

27 Jan 2011

MGH investigators develop novel system to deliver growth factors to chronic wounds

Massachusetts General Hospital investigators have developed a novel system for delivery of growth factors to chronic wounds such as pressure sores and diabetic foot ulcers.

27 Jan 2011

Researchers invent paper microfluidic device for rapid medical diagnostics, chemical analysis

Researchers have invented a technique that uses inexpensive paper to make "microfluidic" devices for rapid medical diagnostics and chemical analysis.

27 Jan 2011

Alcon fourth quarter sales raise 5.7% to $1.81 billion in 2010

Alcon, Inc. reported that global sales rose 5.7 percent to $1.81 billion for the fourth quarter of 2010. Revenue from acquisitions added 100 basis points to sales growth in the quarter, while foreign currency fluctuations reduced reported sales growth by 20 basis points.

27 Jan 2011

Boston Scientific initiates enrollment in comparative Chinese study of PROMUS Element Everolimus-Eluting Stent

Boston Scientific Corporation today announced the beginning of patient enrollment in the PLATINUM China clinical trial, which is designed to evaluate the safety and effectiveness of the Company's PROMUS Element™ Everolimus-Eluting Platinum Chromium Coronary Stent compared to the TAXUS® Liberte® Paclitaxel-Eluting Coronary Stent in the treatment of patients with a single de novo atherosclerotic lesion.

27 Jan 2011

Quest Diagnostics releases new data on oral fluid testing system

OraSure Technologies, the market leader in oral fluid diagnostics, announced today that Quest Diagnostics Incorporated released new data indicating that oral fluid revealed approximately five times more heroin use in the general U.S. workforce than previously believed.

From Quest Diagnostics 27 Jan 2011

Nexstim closes additional equity financing for approximately EUR 11.4 million

Nexstim Oy, a medical device company commercializing noninvasive brain diagnostic and therapy technologies, today announced that it has closed on additional equity financing of approximately EUR 11.4 million.

27 Jan 2011

CyDex stockholders approve merger with Ligand

CyDex Pharmaceuticals, Inc. today announced that its stockholders have voted to approve an Agreement and Plan of Merger between CyDex and Ligand Pharmaceuticals Incorporated and that closing of the transaction has taken place. CyDex will continue its business operations, based in Lenexa, Kansas, as a wholly owned subsidiary of Ligand.

27 Jan 2011

Impulse Monitoring signs agreement with MidMichigan Health

Impulse Monitoring, a leading provider of intraoperative neurophysiological monitoring services to hospitals, today announced that it has signed an agreement with MidMichigan Health, Midland, MI.

26 Jan 2011

First Edition: January 26, 2011

Reporting for KHN, in collaboration with Politico, Bara Vaida writes: "Lobbyists for doctors, hospitals and drug companies are urging lawmakers to derail a planned government panel that health industry officials fear will sharply curb Medicare spending -- a critical revenue source for them".

26 Jan 2011

Ligand announces acquisition of CyDex Pharmaceuticals

Ligand Pharmaceuticals Incorporated today announced it has acquired privately held CyDex Pharmaceuticals, for a combination of cash and contingent payments.

26 Jan 2011

Next generation sequencing on the European growth path: Report

Next Generation Sequencers have found their way into service providing labs and the global biomedical research community. 2010 has seen a serious uptake of Next Generation Sequencing technology, and today it is perceived as an indispensable tool.

26 Jan 2011

Microvisk secures £6 million to launch world's first diagnostic SmartStrip

Microvisk Technologies, the developer of a handheld system to monitor the blood clotting status of patients taking the drug Warfarin, has raised £6 million through a rights issue to existing investors in an oversubscribed round. This is the third successful funding round for Microvisk, which has secured £10.5m in the past 12 months - the largest amount raised by a UK life science company**.

26 Jan 2011

ASTRO reaffirms commitment to quality, issues progress report on patient safety plan

The American Society for Radiation Oncology is continuing its commitment to Target Safely, a six-point patient protection plan developed in January 2010, to improve the safety and quality of radiation therapy treatments and reduce the chances of medical errors.

26 Jan 2011

Spine surgeon successfully treated with RNL Bio's stem cell therapy for Autoimmune Arthritis

RNL BIO CO., LTD, a leading biopharmaceutical company specialized in adult stem cell therapeutics, announced on January 21, 2011 another successful patient report utilizing stem cell therapy on a leading US orthopedic spine surgeon who suffered from Autoimmune Arthritis.

26 Jan 2011

Technology News and Research

BrainScope sponsors 'B-Ahead U.K. Trial' to assess traumatic brain injury

GE's Pathology Imaging Centre of Excellence receives HTX investment under Ontario Flagship Program

State of the Union address includes brief, but clear, defense of health law

Pfenex receives $3.1 million SAIC sub-contract to develop malaria antigen

QIAGEN announces formation of subsidiary in India

New Center for Precision Joint Replacement opens at Salt Lake Regional Medical Center

MGH investigators develop novel system to deliver growth factors to chronic wounds

Researchers invent paper microfluidic device for rapid medical diagnostics, chemical analysis

Alcon fourth quarter sales raise 5.7% to $1.81 billion in 2010

Boston Scientific initiates enrollment in comparative Chinese study of PROMUS Element Everolimus-Eluting Stent

Quest Diagnostics releases new data on oral fluid testing system

Nexstim closes additional equity financing for approximately EUR 11.4 million

CyDex stockholders approve merger with Ligand

Impulse Monitoring signs agreement with MidMichigan Health

First Edition: January 26, 2011

Ligand announces acquisition of CyDex Pharmaceuticals

Next generation sequencing on the European growth path: Report

Microvisk secures £6 million to launch world's first diagnostic SmartStrip

ASTRO reaffirms commitment to quality, issues progress report on patient safety plan

Spine surgeon successfully treated with RNL Bio's stem cell therapy for Autoimmune Arthritis

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News